Powering Up Production: Strategies for Seamless Drug Manufacturing Growth

Brian Moore May 30, 2025 Reading Time: < 3 minutes

Graphic of prescription medication and three orange and white pills

The pace of evolution in drug manufacturing has gone from steady and sustained to rapid leaps in short periods of time. Technological advancements like AI and automation, strategic shifts like reshoring and government priorities, and market dynamics like personalized care and small-batch production are some of primary drivers behind this accelerated time of change and growth.
For pharmaceutical and biopharmaceutical leaders, negotiating this fluid, uncertain environment while maintaining operational excellence, nurturing growth, and ensuring a consistent supply of life-changing medications presents a unique set of challenges. At the heart of successfully scaling operations amid these changes lies a critical element: talent acquisition.

The Dual Challenge: Scaling Production and Securing Talent

To concurrently expand drug manufacturing sites and teams is a massive, multi-faceted undertaking. It requires a significant capital investment for facility build-outs, equipment installation, and process validation to meet stringent industry and regulatory standards. Each of these components alone demands planning and execution. At the same time, an equally demanding challenge often arises: identifying, recruiting, and onboarding qualified talent with highly specialized skills quickly and efficiently.

Pace is paramount in the acquisition of talent. Pharma and biopharma organizations that struggle in this area are at risk. A primary threat is lack of skilled talent — the life sciences and pharmaceutical industries are expected to face a 35% shortfall in talent by 2030.^1. The specialized nature of drug manufacturing roles — from quality control and validation specialists to experienced manufacturing technicians — means that pools of quality talent can be shallow. How does that look in reality? In a 2023 Deloitte survey², 83% of pharmaceutical and life sciences organizations experienced difficulty finding skilled talent — 75% anticipated the shortage would worsen through 2028.

Any delay in securing the right people can snowball, potentially leading to significant risks such as missed production timelines, compromised product quality, and — worst of all — an inability to meet market demand. This dual challenge necessitates a strategic and proactive approach to workforce planning.

Strategic Pillars for Seamless Drug Manufacturing Growth

Proactive workforce planning: Meaningful growth in drug manufacturing begins with planning and foresight. Proactive workforce planning involves meticulously forecasting future talent needs based on projected expansion plans, anticipated production targets, and evolving regulatory requirements. Forward-thinking organizations can anticipate skill gaps and initiate recruitment efforts well in advance. A crucial aspect of this pillar is early engagement with experienced, specialized staffing partners like Medix who possess an in-depth understanding of the pharmaceutical and biopharmaceutical industries. Their insights can be invaluable in accurately assessing talent availability and developing effective staffing strategies.
Flexible staffing models: With uncertainty and rapid growth driving the industry forward, rigidity in staffing can be a significant road block. This is where flexible staffing models prove invaluable. Using a mix of contract, contract-to-hire, and direct-hire options allows drug manufacturers to adapt quickly to fluctuating demands. Contract professionals can fill immediate talent gaps during peak production periods or facility ramp-ups, providing specialized expertise without the long-term commitment — and cost — of a permanent hire. Contract-to-hire arrangements offer a valuable “try before you buy” option, providing a chance to assess a candidate’s fit and performance before extending a permanent offer. Direct hire is the final answer for core, long-term positions. This agility ensures drug manufacturers stick to production timelines and meet quality standards.
Building a resilient talent pipeline: Beyond urgent staffing needs, sustainable growth and a robust, resilient talent pipeline go hand in hand. Companies need to create and implement strategies for attracting skilled manufacturing specialists. Just as important is a plan for retaining that talent. Compensation and benefits are attractive and effective, but so are opportunities for professional development, a positive company culture, and a path to career advancement. Partnering with staffing agencies that boast deep industry networks is paramount here. Such agencies have fruitful relationships with top-tier talent, often reaching candidates who may not be actively seeking new roles but are open to exploring their opportunities. This proactive approach to talent acquisition ensures a continuous influx of qualified talent to support ongoing and future growth initiatives.

Medix: Your Partner in Scaling Drug Manufacturing Operations

With almost 25 years experience partnering with pharmaceutical and biopharmaceutical companies, Medix understands the intricate demands of both. This deep knowledge and our proven, award-winning staffing solutions mean we are uniquely positioned to support companies as they scale their drug manufacturing operations. Our team is familiar with the specialized skills and qualifications required in this highly regulated environment, from quality control technicians and validation engineers to manufacturing field service techs and research scientists.

Pharmaceutical and biopharmaceutical organizations partner with us for flexible staffing solutions that allow them to adapt to the inherent uncertainty and rapid growth associated with site expansions and reshoring initiatives. Whether you need to quickly ramp up a new production line with a team of contract specialists, find experienced professionals for a critical validation project, or identify permanent leaders for your growing operations, Medix has the expertise and the network to deliver.

Powering Your Growth with the Right Talent Strategy

A strategic and flexible approach to talent acquisition is not merely an advantage in drug manufacturing. It is a necessity for sustained growth. The ability to quickly and efficiently secure qualified talent during periods of expansion or industry shifts is the key to maintaining production, ensuring quality, and capitalizing on market opportunities.

Medix stands as your trusted partner, uniquely capable of providing the right talent at the right time. Our deep industry knowledge, nationwide talent network of over 3 million candidates, and flexible staffing solutions empower your organization to navigate the complexities of growth with confidence.

Ready to power up production and experience sustained growth? Contact Medix today to get started.

References: